Stockreport

TScan Therapeutics Named Top Place to Work by The Boston Globe for Two Consecutive Years [Yahoo! Finance]

TScan Therapeutics, Inc.  (TCRX) 
PDF the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced it has been named one of the Top [Read more]